raloxifene has been researched along with mobic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beerli, R; Blanz, J; Drückes, P; Fendrich, G; Gassmann, E; Glatthar, R; Gutmann, S; Hornfeld, J; Martiny-Baron, G; Mattes, H; Möbitz, H; Peel, JE; Sparrer, H; Spence, F; Stojanovic, A; Troxler, T | 1 |
1 review(s) available for raloxifene and mobic
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for raloxifene and mobic
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors.
Topics: Animals; Crystallography, X-Ray; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Male; MAP Kinase Kinase Kinases; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2016 |